Prof. Dr. Necdet Üskent
Medical Oncology. The branch of medicine that looks after cancers, illnesses in which cells of the body multiply out of control and form tumours.
Is this your profile? Claim it and verify your details.
Claim profileThe CV on this page was translated automatically from its original language. See the original
Person ↔ Disease
Which topics does this doctor work on?
Medical areas of interest the doctor lists on their own profile on the institution’s website. Source: anadolusaglik.org.
- Breast cancer
- Gastrointestinal cancers
- Lung cancers
- Lymphomas
- Myeloma
- Medical oncology
- Haematology
CV
Education and experience
Professor Necdet Üskent has worked at Anadolu Sağlık Merkezi since 2005 as a specialist in medical oncology and haematology and as Coordinator of Oncological Sciences.
Experience
- ExperienceWestminster Hospitalanadolusaglik.org
- ExperienceCharing Cross, Hammersmithanadolusaglik.org
- ExperienceRoyal Free Hospitalanadolusaglik.org
- ExperienceUniversity College Hospitalanadolusaglik.org
- ExperienceCantonal Hospital Baselanadolusaglik.org
- ExperienceIstanbul GATA Medical Oncology and Haematology Clinicsanadolusaglik.org
- ExperienceKadir Has University (Bilim University) Faculty of Medicine, Department of Internal Medicineanadolusaglik.org
- ExperienceFlorence Nightingale Hospitalanadolusaglik.org
- ExperienceAnadolu Sağlık Merkezianadolusaglik.org
Education
- 1971Ankara University Faculty of Medicine, Ankaraanadolusaglik.org
- 1979Specialty training: GATA Faculty of Medicine, Ankaraanadolusaglik.org
- 1982Specialty training: Wadley Institutes of Molecular Medicine, Granville-Morton Cancer Hospital, Medical Oncology and Haematology Subspecialtyanadolusaglik.org
- EducationAssistant Professor: GATA Faculty of Medicine, Department of Medical Oncologyanadolusaglik.org
- 1984Associate Professor: GATA Faculty of Medicine, Department of Medical Oncology, Ankaraanadolusaglik.org
- 1989Professor: GATA, Medical Oncology and Haematology Clinics, Istanbulanadolusaglik.org
Trust
Where does this information come from?
The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.
- SpecialtyMedical Oncologyanadolusaglik.orgFrom source
- Department name in the sourceMedikal Onkoloji, Hematolojik Onkolojianadolusaglik.orgFrom source
- InstitutionAnadolu Sağlık Merkezi Hastanesianadolusaglik.orgFrom source
- Publications143 publicationsanadolusaglik.org profile pageFrom source
- Last synchronised11 November 2026 22:59https://www.anadolusaglik.org/doktor/necdet-uskentanadolusaglik.org
Scientific work
Publications
-
N.Üskent, M.Danacı, M.Özel, İ.Öztek,Z.Altınok, B.S.Cebeci, M.Altın, S.Yürütken, N.Doğan, F.Karslı : Complete response to alpha interferon 2b in classic (AIDS non-related) Kaposi’s Sarcoma and an unusual toxicity of interferon. Kanser. Turk J Cancer. 1991; 21(2): 83-88.
Source: anadolusaglik.org profile page
-
N.Üskent, M.Danacı, M.Özel: Kanser tedavisinde yeni ufuklar. Endojen koloni stimüle edici faktörlerin (CSF) klinik kullanımı. Türk Onkoloji Dergisi. 1991; 6 (3-4): 1205-1210.
Source: anadolusaglik.org profile page
-
M.Danacı,N.Üskent, K.Doğruöz, İ.Öztek, Z.Altınok, M.Özel: Nadir rastlanan bir olgu : Etofenamatın topikal kullanımına bağlı toksik purpura. Sendrom1991;3:19-22.
Source: anadolusaglik.org profile page
-
N.Üskent, M.Danacı, M.Özel, H.Tor, G.Öztürk, İ.Öztek, F.Karslı, T.Çelenk, Y.Z.Yergök: Ovarian cancer metastasis to thyroid and cervical lymph node. Turk J Cancer.1992;22(1):39-43. 5-FU,Etposid ve Yüksek Doz leucoverine(FEL) Kombinasyonu ile aldığımımız sonuçlar.GATA Bülteni 34: 563-568,1992
Source: anadolusaglik.org profile page
-
Üskent N. Danacı M. Haksever H. İleri evre Kolorektal kanserlerde
Source: anadolusaglik.org profile page
-
N.Üskent, M.Danacı, M.Özel, M.Yaylacı, H.Tor : Treatment of severe aplastic anemia with cylosporin-A and high dose methylprednisolone. Marmara Medical Journal. 1992;5(1):27-30.
Source: anadolusaglik.org profile page
-
M.Danacı, L.Dumanhan, M.Özel, H.Tor, N.Üskent : Diabetik hiperlipidemilerde gemfibrozilin etkisi. GATA Bülteni. 1992; 34: 285-295.
Source: anadolusaglik.org profile page
-
H.Tor, M.Yaylacı, N.Üskent, A.Acaroğlu, M.Danacı, M.Özel: Diabetik nefropatinin evrelendirilmesi ve erken tanımında beta 2 mikroglobulinin değeri. GATA Bülteni. 1992; 34: 691-704.
Source: anadolusaglik.org profile page
-
N.Üskent, Z. Mete, M.Danacı, M.Özel, H.Tor, İ.Göçmen, N.Haksever: Akut ve kronik idyopatik trombositopenik purpurada yüksek doz intravenöz immünglobulin G uygulamalarından aldığımız sonuçlar. GATA Bülteni. 1992; 34: 859-865.
Source: anadolusaglik.org profile page
-
S.Hülagü, İ.Dinç, M.Altın, M.Danacı, M.Özel, Z.Çankır, G.Öztürk, M.Yaylacı, N.Üskent, S.Yürütken : Evaluation of the effects of octreotide on portal hemodynamics using pulsed Doppler ultrasonography in patients with chronic liver disease. Marmara Medical Journal. 1993; 6(4): 131-136.
Source: anadolusaglik.org profile page